Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40257-016-0245-x http://scihub22266oqcxt.onion/10.1007/s40257-016-0245-x C5360829!5360829!28155090     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Clin+Dermatol 2017 ; 18 (2): 169-91 Nephropedia Template TP {{tp|p=28155090|t=2017. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review |pdf=|usr=}}{{28155090}} gab.com Text Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review JO: Am J Clin Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=28155090 #FOAvip Background: The management of acne in adult females is problematic, with many having a history of treatment failure and some having a predisposition to androgen excess. Alternatives to oral antibiotics and combined oral contraceptives (COCs) are required. Objective: Our aim was to conduct a hybrid systematic review of the evidence for benefits and potential harms of oral spironolactone in the management of acne in adult females. Methods: The review was conducted according to a previously published protocol. Three reviewers independently selected relevant studies from the search results, extracted data, assessed the risk of bias, and rated the quality of the evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Results: Ten randomized controlled trials (RCTs) and 21 case series were retrieved. All trials were assessed as being at a ?high risk? of bias, and the quality of evidence was rated as low or very low for all outcomes. Apart from one crossover trial that demonstrated statistical superiority of a 200 mg daily dose versus inflamed lesions compared with placebo, data from the remaining trials were unhelpful in establishing the degree of efficacy of lower doses versus active comparators or placebo. Menstrual side effects were significantly more common with the 200 mg dose; frequency could be significantly reduced by concomitant use of a COC. Pooling of results for serum potassium supported the recent recommendation that routine monitoring is not required in this patient population. Conclusion: This systematic review of RCTs and case series identified evidence of limited quality to underpin the expert endorsement of spironolactone at the doses typically used (?100 mg/day) in everyday clinical practice. Electronic supplementary material: The online version of this article (doi:10.1007/s40257-016-0245-x) contains supplementary material, which is available to authorized users. Twit Text FOAVip Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review ????Am J Clin Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=28155090 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28155090 #FOAvip English Wikipedia <ref>{{Cite pmid|28155090}}</ref> Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review #MMPMID28155090 Layton AM; Eady EA; Whitehouse H; Del Rosso JQ; Fedorowicz Z; van Zuuren EJ Am J Clin Dermatol 2017[]; 18 (2): 169-91 PMID28155090show ga Background: The management of acne in adult females is problematic, with many having a history of treatment failure and some having a predisposition to androgen excess. Alternatives to oral antibiotics and combined oral contraceptives (COCs) are required. Objective: Our aim was to conduct a hybrid systematic review of the evidence for benefits and potential harms of oral spironolactone in the management of acne in adult females. Methods: The review was conducted according to a previously published protocol. Three reviewers independently selected relevant studies from the search results, extracted data, assessed the risk of bias, and rated the quality of the evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Results: Ten randomized controlled trials (RCTs) and 21 case series were retrieved. All trials were assessed as being at a ?high risk? of bias, and the quality of evidence was rated as low or very low for all outcomes. Apart from one crossover trial that demonstrated statistical superiority of a 200 mg daily dose versus inflamed lesions compared with placebo, data from the remaining trials were unhelpful in establishing the degree of efficacy of lower doses versus active comparators or placebo. Menstrual side effects were significantly more common with the 200 mg dose; frequency could be significantly reduced by concomitant use of a COC. Pooling of results for serum potassium supported the recent recommendation that routine monitoring is not required in this patient population. Conclusion: This systematic review of RCTs and case series identified evidence of limited quality to underpin the expert endorsement of spironolactone at the doses typically used (?100 mg/day) in everyday clinical practice. Electronic supplementary material: The online version of this article (doi:10.1007/s40257-016-0245-x) contains supplementary material, which is available to authorized users. äOral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Syste(epmc).pdf DeepDyve Pubget Overpricing